Verrica Pharmaceuticals Inc Sustainability Reports
Verrica Pharmaceuticals Inc. is a commercial-stage dermatology therapeutics company focused on developing and commercializing pharmaceutical products for the treatment of skin diseases. Its primary commercial product is YCANTH (VP-102) for the treatment of molluscum contagiosum.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493002L68H6THU5GW50
5 reports from 2019 to 2023